Gadolinium Retention in Human Bone Tissue in Pediatric Patients: A Comparison of Dotarem Versus MultiHance MRI Contrast Agents View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2017-2019

ABSTRACT

The purpose of this study is to compare contrast agents, Dotarem or MultiHance. The study will test to see how much of these two contrast agents are deposited in the bones or tissues of pediatric patients. The patients receiving contrast will then be compared against pediatric patients who have not received any contrast prior to cardiac surgeries. Detailed Description When injected into the body, gadolinium contrast medium makes certain tissues, abnormalities or disease processes more clearly visible on a magnetic resonance imaging (MRI) scans and therefore gadolinium based contrast agents (GBCAs) are widely used in medical imaging. Recently, new evidence suggests that following GBCA administration, gadolinium can be deposited in body tissues even in the presence of normal renal function. Therefore, it is essential to ensure that significant accumulation of free Gd3+ is not occurring in the bones of children undergoing clinical contrasted MRI scans. This is particularly important for those pediatric patients who will undergo multiple repeated MRI exams throughout their lifetime and thereby be exposed to a large cumulative dose of gadolinium contrast. As the differences in stability between the various GBCAs may be a factor in gadolinium exposure, the primary objective of this study is to assess gadolinium deposition in the bones of pediatric patients in two patient groups: 1. patients who received IV administration of gadolinium contrast agent (Dotarem) and 2. patients who received IV administration of gadolinium contrast agent (MultiHance). Once acquired the samples will be analyzed at an off-site facility, National Institute of Standards and Technology (NIST), using standardized equipment which has been certified for measuring gadolinium concentration in contrast agent samples. A signed agreement for the transfer of non-proprietary biological material between MUSC and NIST covers the transfer of the samples. More... »

URL

https://clinicaltrials.gov/show/NCT03337594

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The purpose of this study is to compare contrast agents, Dotarem or MultiHance. The study will test to see how much of these two contrast agents are deposited in the bones or tissues of pediatric patients. The patients receiving contrast will then be compared against pediatric patients who have not received any contrast prior to cardiac surgeries.\n\nDetailed Description\nWhen injected into the body, gadolinium contrast medium makes certain tissues, abnormalities or disease processes more clearly visible on a magnetic resonance imaging (MRI) scans and therefore gadolinium based contrast agents (GBCAs) are widely used in medical imaging. Recently, new evidence suggests that following GBCA administration, gadolinium can be deposited in body tissues even in the presence of normal renal function. Therefore, it is essential to ensure that significant accumulation of free Gd3+ is not occurring in the bones of children undergoing clinical contrasted MRI scans. This is particularly important for those pediatric patients who will undergo multiple repeated MRI exams throughout their lifetime and thereby be exposed to a large cumulative dose of gadolinium contrast. As the differences in stability between the various GBCAs may be a factor in gadolinium exposure, the primary objective of this study is to assess gadolinium deposition in the bones of pediatric patients in two patient groups: 1. patients who received IV administration of gadolinium contrast agent (Dotarem) and 2. patients who received IV administration of gadolinium contrast agent (MultiHance). Once acquired the samples will be analyzed at an off-site facility, National Institute of Standards and Technology (NIST), using standardized equipment which has been certified for measuring gadolinium concentration in contrast agent samples. A signed agreement for the transfer of non-proprietary biological material between MUSC and NIST covers the transfer of the samples.", 
    "endDate": "2019-10-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03337594", 
    "keywords": [
      "gadolinium", 
      "human bone", 
      "pediatric patient", 
      "MRI contrast agent", 
      "contrast agent", 
      "Bone and Bone", 
      "tissue", 
      "patient", 
      "contrast", 
      "Thoracic Surgery", 
      "body", 
      "contrast medium", 
      "certain tissue", 
      "abnormality", 
      "disease process", 
      "Magnetic Resonance Imaging", 
      "Diagnostic Imaging", 
      "evidence", 
      "body tissue", 
      "normal renal function", 
      "significant accumulation", 
      "child", 
      "lifetime", 
      "cumulative dose", 
      "difference", 
      "stability", 
      "primary objective", 
      "patient group", 
      "Organization and Administration", 
      "sample", 
      "off-site", 
      "National Institute of standard Technology", 
      "National Institute of standard and Technology", 
      "agreement", 
      "transfer", 
      "biological material"
    ], 
    "name": "Gadolinium Retention in Human Bone Tissue in Pediatric Patients: A Comparison of Dotarem Versus MultiHance MRI Contrast Agents", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03337594"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00025.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.259828.c", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.94225.38", 
        "type": "Organization"
      }
    ], 
    "startDate": "2017-10-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1097/00004728-198803000-00015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028697840"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejrad.2008.01.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033886194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10534-008-9135-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040742030", 
          "https://doi.org/10.1007/s10534-008-9135-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.rli.0000186569.32408.95", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041126766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/17425250902873796", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042658358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejrad.2008.01.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046093415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jmri.21966", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051144853"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1039/b905145g", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053444542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079664203", 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03337594"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03337594'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03337594'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03337594'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03337594'


 

This table displays all metadata directly associated to this object as RDF triples.

84 TRIPLES      16 PREDICATES      61 URIs      45 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03337594 schema:about anzsrc-for:3053
2 schema:description The purpose of this study is to compare contrast agents, Dotarem or MultiHance. The study will test to see how much of these two contrast agents are deposited in the bones or tissues of pediatric patients. The patients receiving contrast will then be compared against pediatric patients who have not received any contrast prior to cardiac surgeries. Detailed Description When injected into the body, gadolinium contrast medium makes certain tissues, abnormalities or disease processes more clearly visible on a magnetic resonance imaging (MRI) scans and therefore gadolinium based contrast agents (GBCAs) are widely used in medical imaging. Recently, new evidence suggests that following GBCA administration, gadolinium can be deposited in body tissues even in the presence of normal renal function. Therefore, it is essential to ensure that significant accumulation of free Gd3+ is not occurring in the bones of children undergoing clinical contrasted MRI scans. This is particularly important for those pediatric patients who will undergo multiple repeated MRI exams throughout their lifetime and thereby be exposed to a large cumulative dose of gadolinium contrast. As the differences in stability between the various GBCAs may be a factor in gadolinium exposure, the primary objective of this study is to assess gadolinium deposition in the bones of pediatric patients in two patient groups: 1. patients who received IV administration of gadolinium contrast agent (Dotarem) and 2. patients who received IV administration of gadolinium contrast agent (MultiHance). Once acquired the samples will be analyzed at an off-site facility, National Institute of Standards and Technology (NIST), using standardized equipment which has been certified for measuring gadolinium concentration in contrast agent samples. A signed agreement for the transfer of non-proprietary biological material between MUSC and NIST covers the transfer of the samples.
3 schema:endDate 2019-10-01T00:00:00Z
4 schema:keywords Bone and Bone
5 Diagnostic Imaging
6 MRI contrast agent
7 Magnetic Resonance Imaging
8 National Institute of standard Technology
9 National Institute of standard and Technology
10 Organization and Administration
11 Thoracic Surgery
12 abnormality
13 agreement
14 biological material
15 body
16 body tissue
17 certain tissue
18 child
19 contrast
20 contrast agent
21 contrast medium
22 cumulative dose
23 difference
24 disease process
25 evidence
26 gadolinium
27 human bone
28 lifetime
29 normal renal function
30 off-site
31 patient
32 patient group
33 pediatric patient
34 primary objective
35 sample
36 significant accumulation
37 stability
38 tissue
39 transfer
40 schema:name Gadolinium Retention in Human Bone Tissue in Pediatric Patients: A Comparison of Dotarem Versus MultiHance MRI Contrast Agents
41 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03337594
42 schema:sdDatePublished 2019-03-07T15:27
43 schema:sdLicense https://scigraph.springernature.com/explorer/license/
44 schema:sdPublisher N39cd252010434d329d8e23f32460f897
45 schema:sponsor https://www.grid.ac/institutes/grid.259828.c
46 https://www.grid.ac/institutes/grid.94225.38
47 schema:startDate 2017-10-01T00:00:00Z
48 schema:subjectOf sg:pub.10.1007/s10534-008-9135-x
49 https://app.dimensions.ai/details/publication/pub.1079664203
50 https://doi.org/10.1002/jmri.21966
51 https://doi.org/10.1016/j.ejrad.2008.01.023
52 https://doi.org/10.1016/j.ejrad.2008.01.025
53 https://doi.org/10.1039/b905145g
54 https://doi.org/10.1097/00004728-198803000-00015
55 https://doi.org/10.1097/01.rli.0000186569.32408.95
56 https://doi.org/10.1517/17425250902873796
57 schema:url https://clinicaltrials.gov/show/NCT03337594
58 sgo:license sg:explorer/license/
59 sgo:sdDataset clinical_trials
60 rdf:type schema:MedicalStudy
61 N39cd252010434d329d8e23f32460f897 schema:name Springer Nature - SN SciGraph project
62 rdf:type schema:Organization
63 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
64 rdf:type schema:DefinedTerm
65 sg:pub.10.1007/s10534-008-9135-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1040742030
66 https://doi.org/10.1007/s10534-008-9135-x
67 rdf:type schema:CreativeWork
68 https://app.dimensions.ai/details/publication/pub.1079664203 schema:CreativeWork
69 https://doi.org/10.1002/jmri.21966 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051144853
70 rdf:type schema:CreativeWork
71 https://doi.org/10.1016/j.ejrad.2008.01.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033886194
72 rdf:type schema:CreativeWork
73 https://doi.org/10.1016/j.ejrad.2008.01.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046093415
74 rdf:type schema:CreativeWork
75 https://doi.org/10.1039/b905145g schema:sameAs https://app.dimensions.ai/details/publication/pub.1053444542
76 rdf:type schema:CreativeWork
77 https://doi.org/10.1097/00004728-198803000-00015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028697840
78 rdf:type schema:CreativeWork
79 https://doi.org/10.1097/01.rli.0000186569.32408.95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041126766
80 rdf:type schema:CreativeWork
81 https://doi.org/10.1517/17425250902873796 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042658358
82 rdf:type schema:CreativeWork
83 https://www.grid.ac/institutes/grid.259828.c schema:Organization
84 https://www.grid.ac/institutes/grid.94225.38 schema:Organization
 




Preview window. Press ESC to close (or click here)


...